Trim 30% into $475-480 resistance; hard stop at $458 on remaining 70%
Underweight with trim-execution at resistance — not pure Hold, not full Sell. The four-factor bearish convergence is operationally meaningful: Q2 2026 marks first gross margin contraction in five years (47.7% vs 49.3%, 160 bp compression), capital returns at 145% of FCF ($7.4B against $5.09B FCF) funded by $6.3B incremental net debt, technical structure bearish with price below all three major MAs and confirmed death cross, and macro structurally hostile with 10Y at multi-decade highs and 97% Polymarket probability of zero Fed cuts in 2026. However, underlying business remains structurally intact with 80% contracted take-or-pay revenue, 0.727 beta, A-rated credit, 1.67x net debt/EBITDA, 31-year dividend growth streak, 28% operating margins, 18.4% ROE, oligopoly structure — collectively capping absolute drawdown and warranting 70% residual exposure. The 30% trim size is calibrated to meaningfully reduce concentration risk into a Q3 print that could gap down 6-8% through the $458 stop on a single session, while preserving structural moat exposure.
| Position | Action |
|---|---|
| Price reaches $475-480 triple-resistance zone (50 SMA at $480.12, 200 SMA at $483.15, Bollinger upper at $480.30) | Trim 20% of position via limit orders |
| Tier 1 fills with acceptance above $480 | Trim additional 10% at $481-483 |
| Zone not tested within 5 sessions | Execute remaining trim at market to avoid chasing |
| Confirmed daily close below $458 (Sep 17 swing low) | Exit remaining 70% core position with measured downside target $445-454 |
| Weekly close below $445 on rising volume | Exit remaining 70% to zero |
| Hedge residual single-name risk into Q3 binary event | Consider $465 strike protective puts, 1-2 months out |
Linde is a fortress quality compounder with accelerating earnings momentum, a structurally widening competitive moat, $5B in annual FCF, and technicals coiled for a breakout—all trading at a fair 24x forward P/E despite being 14% off recent highs.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $469.67 | bearish |
| 50 SMA | $480.12 | bearish |
| 200 SMA | $483.15 | neutral |
| MACD Line | -2.87 | bearish |
| MACD Signal | -4.78 | bearish |
| MACD Histogram | +1.91 | bullish |
| RSI (14) | 46.11 | neutral |
| Bollinger Upper Band | $480.30 | neutral |
| Bollinger Middle (20 SMA) | $467.53 | neutral |
| Bollinger Lower Band | $454.77 | neutral |
| ATR |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Potential upgrade from Underweight
↩ rebuts: “Bear claim that LIN is a 'mature, low-growth industrial'”
EV: +4–5% upside on breakout above $480 to target $490–493; extended target $490–500 · concedes: 5-year revenue CAGR is modest at ~2.5%; CapEx/revenue at 15.5% is elevated; Trailing P/E of 30x is above the forward multiple; USD strengthening creates modest translation drag (~60% of sales are USD-reported)
LIN is a high-multiple industrial gas company (24x forward P/E, 30x trailing P/E) sitting below every major moving average, with margin signals already cracking, buyback-driven EPS inflation masking slower organic growth, and a macro environment (rising yields, no Fed cuts, USD strength) actively hostile to its valuation.
EV: -3% to -5% (bearish target: $445-454) · concedes: The franchise is real; Margins are best-in-class; FCF generation is durable; Capital return program is shareholder-friendly in intent; Q3 earnings could provide a catalyst if margin compression reverses; Accenture and IBM quality compounder rallies show the strategy works when fundamentals are solid
→ vs conservative: Conservative 'hold' requires believing the Fed will pivot despite zero cuts priced at 97%, the gross margin print is noise despite five years of expansion, and price action is a bear trap despite all moving averages and momentum aligned bearishly—that is denial, not conservatism; 12-15% equity value will be donated to routine mean reversion
→ vs neutral: Neutral 'wait for confirmation above $480 or below $458' makes the analyst a liquidity-taker rather than liquidity-maker; by the time daily close confirms with volume, the trim opportunity is gone; MACD histogram positive is lagging inside downtrend, RSI bounce from 29 to 46 is corrective wave, not reversal; listing five indicators as 'mixed' hides that structural signals are uniformly bearish
| 7.83 |
| neutral |
Support: 454.77 · 458 · 467.53 | Resistance: 474.65 · 480 · 483 · 489
LIN exhibits a mixed technical picture with bearish short-term structure (price below all MAs) but improving momentum indicators. The MACD histogram has turned positive and expanding (+1.91), RSI has recovered from oversold (46.11 from sub-30), and the 200 SMA remains in an upward trajectory, indicating the long-term uptrend is intact. Key resistance clusters at $480-483 (50 SMA + Bollinger upper + 200 SMA convergence), with strong support at $458-460 (September swing lows) and $454.77 (Bollinger lower band). Volatility compression (ATR declining from 12.78 to 7.83, Bollinger bandwidth narrowing) suggests a breakout is imminent, though direction remains unclear until price decisively clears $480 or breaks below $458.
Market Cap
$216.41 B
52-Week High
$548.20
52-Week Low
$387.78
P/E (TTM)
30.25x
Forward P/E
24.00x
PEG Ratio
1.83
Price / Book
5.54x
Beta
0.73
Dividend Yield
1.35%
Revenue (TTM)
$35.45 B
Revenue (FY2025)
$33.986 B
Revenue (FY2024)
$33.005 B
Revenue (FY2023)
$32.854 B
Revenue (FY2022)
$33.364 B
Revenue (FY2021)
$30.793 B
Gross Margin (TTM)
48.3%
Gross Margin (FY2025)
48.8%
Gross Margin (FY2024)
48.1%
Gross Margin (FY2023)
46.7%
Gross Margin (FY2022)
41.7%
Gross Margin (FY2021)
38.4%
Operating Margin (TTM)
28.1%
Operating Margin (FY2025)
27.2%
Operating Margin (FY2024)
27.4%
Operating Margin (FY2023)
25.6%
EBITDA Margin (TTM)
39.0%
Net Margin (TTM)
20.4%
Net Margin (FY2025)
20.3%
Net Margin (FY2024)
19.9%
Net Margin (FY2023)
18.9%
Net Income (FY2025)
$6,898 M
Net Income (FY2024)
$6,565 M
Net Income (FY2023)
$6,199 M
Diluted EPS (TTM)
$15.52
Forward EPS
$19.56
Diluted EPS (FY2025)
$14.61
Diluted EPS (FY2024)
$13.62
Diluted EPS (FY2023)
$12.59
Diluted EPS (FY2022)
$8.23
Diluted EPS (FY2021)
$7.40
ROE (TTM)
18.4%
ROA (TTM)
7.2%
Interest Coverage (EBIT/Interest)
20.2x
Tax Rate (FY2025)
22.4%
Total Assets (Q2'26)
$88.35 B
Total Equity (Q2'26)
$40.63 B
Stockholders' Equity (Q2'26)
$39.081 B
Total Debt (Q2'26)
$28.01 B
Net Debt (Q2'26)
$23.12 B
Net Debt / EBITDA
1.76x
Current Ratio (Q2'26)
0.88
Debt/Equity (book) (Q2'26)
0.69x
Goodwill + Intangibles (Q2'26)
$39.491 B
Net PPE (Q2'26)
$29.170 B
Working Capital (Q2'26)
-$1,951 M
Operating Cash Flow (FY2025)
$10.35 B
Free Cash Flow (FY2025)
$5.09 B
CapEx (FY2025)
$5.26 B
Dividends Paid (FY2025)
$2.81 B
Share Repurchases (FY2025)
$4.60 B
Q2 2026 Revenue
$9.29 B
Q2 2026 YoY Revenue Growth
+9.3%
Q2 2026 Diluted EPS
$4.15
Q2 2026 FCF
$0.83 B
Q1 2026 Revenue
$8,781 M
Q1 2026 Diluted EPS
$3.98
Q4 2025 Revenue
$8,764 M
Q4 2025 Diluted EPS
$3.26
Diluted Shares Outstanding (FY2022)
504 M
Diluted Shares Outstanding (FY2025)
473 M
Diluted Shares Outstanding (Q2'26)
464.5 M
SG&A (FY2025)
$3.43 B
SG&A % of Revenue (FY2025)
10.1%
R&D Intensity
0.43%
FCF Margin
15%
CapEx / Revenue (FY2025)
15.5%
Treasury Stock (Q2'26)
$12.93 B
Treasury Stock (YE2024)
$7.25 B
Strengths
Concerns
Linde plc operates as the world's largest industrial gases and engineering company, serving healthcare, electronics, manufacturing, and clean energy end-markets through a contracted on-site/pipeline business model alongside merchant and packaged gas delivery. The company has achieved exceptional margin expansion over 5 years (gross margin 38.4% to 48.8%, operating margin 17.4% to 27.2%) with EPS CAGR of ~18.5% despite modest ~2.5% revenue growth, driven by post-merger pricing actions, project backlog execution, and operating leverage on its high-fixed-cost asset base. The fortress balance sheet (1.76x net debt/EBITDA, 20x interest coverage) supports aggressive capital return of ~$7.4B annually through dividends and buybacks, while elevated FY25 CapEx of $5.26B funds hydrogen and clean-energy projects with long-term contracted visibility.
Macro: Hawkish Fed pricing persists with 97% probability of no rate cuts in 2026 (~$8.7M Polymarket volume); 10-year Treasury yields at highest since 2002 with biggest monthly gain since 2022. US recession odds at 8% (down 2pp w/w), trending lower. PCE report reinforced sticky-inflation regime. Gold at $4,147.70 (+0.27%); silver firmer post-PCE. IT services rallying (Accenture +23%, IBM +5%) signals risk-on for quality compounders. No LIN-specific company news in past two weeks.